Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests

This study has been completed.

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00108212

Purpose

The purpose of this study is to evaluate different diets and the effects of blood measures or inflammation and endothelial function in association with genetics tending to abnormal blood test levels.

Condition	Intervention
Dyslipidemia	Behavioral: Diet

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Placebo Control, Crossover Assignment
Official Title:	Clinical Implications of Genetic Alterations in TG Rich Lipoproteins

Further study details as provided by Department of Veterans Affairs:

Study Start Date:	January 2005
Estimated Study Completion Date:	December 2007

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Polymorphism in Apo C3 promoter and normal controls.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00108212

Locations

United States, Maryland
VA Maryland Health Care System
Baltimore, Maryland, United States, 21201

Sponsors and Collaborators

Department of Veterans Affairs

More Information

Study ID Numbers:	CARD-005-03S
Study First Received:	April 14, 2005
Last Updated:	April 30, 2007
ClinicalTrials.gov Identifier:	NCT00108212
Health Authority:	United States: Federal Government

Keywords provided by Department of Veterans Affairs:

Diet
triglyceride
inflammation
Genetic polymorphism

Study placed in the following topic categories:

Metabolic Diseases
Metabolic disorder
Dyslipidemias
Lipid Metabolism Disorders
Inflammation

ClinicalTrials.gov processed this record on January 15, 2009